nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—Fatigue—Altretamine—ovarian cancer	0.0115	0.0148	CcSEcCtD
Bromazepam—Asthenia—Altretamine—ovarian cancer	0.00961	0.0123	CcSEcCtD
Bromazepam—Ataxia—Chlorambucil—ovarian cancer	0.00911	0.0116	CcSEcCtD
Bromazepam—Dizziness—Altretamine—ovarian cancer	0.00886	0.0113	CcSEcCtD
Bromazepam—Vomiting—Altretamine—ovarian cancer	0.00852	0.0109	CcSEcCtD
Bromazepam—Haemoglobin decreased—Docetaxel—ovarian cancer	0.00842	0.0108	CcSEcCtD
Bromazepam—Cardiac arrest—Topotecan—ovarian cancer	0.0082	0.0105	CcSEcCtD
Bromazepam—Cardiac arrest—Melphalan—ovarian cancer	0.00803	0.0103	CcSEcCtD
Bromazepam—Nausea—Altretamine—ovarian cancer	0.00796	0.0102	CcSEcCtD
Bromazepam—Cardiac failure—Vinorelbine—ovarian cancer	0.00756	0.00966	CcSEcCtD
Bromazepam—Hallucination—Chlorambucil—ovarian cancer	0.00667	0.00852	CcSEcCtD
Bromazepam—Muscular weakness—Vinorelbine—ovarian cancer	0.0065	0.00831	CcSEcCtD
Bromazepam—Connective tissue disorder—Melphalan—ovarian cancer	0.00574	0.00734	CcSEcCtD
Bromazepam—Tremor—Chlorambucil—ovarian cancer	0.00546	0.00698	CcSEcCtD
Bromazepam—Agitation—Chlorambucil—ovarian cancer	0.00536	0.00685	CcSEcCtD
Bromazepam—Malnutrition—Topotecan—ovarian cancer	0.00519	0.00664	CcSEcCtD
Bromazepam—Cardiac failure—Paclitaxel—ovarian cancer	0.00508	0.0065	CcSEcCtD
Bromazepam—Convulsion—Chlorambucil—ovarian cancer	0.00505	0.00646	CcSEcCtD
Bromazepam—Connective tissue disorder—Vinorelbine—ovarian cancer	0.00501	0.00641	CcSEcCtD
Bromazepam—Muscle spasms—Topotecan—ovarian cancer	0.00499	0.00638	CcSEcCtD
Bromazepam—Confusional state—Chlorambucil—ovarian cancer	0.0048	0.00613	CcSEcCtD
Bromazepam—Cardiac disorder—Vinorelbine—ovarian cancer	0.00474	0.00605	CcSEcCtD
Bromazepam—Cardiac arrest—Paclitaxel—ovarian cancer	0.00472	0.00603	CcSEcCtD
Bromazepam—Ataxia—Paclitaxel—ovarian cancer	0.00466	0.00596	CcSEcCtD
Bromazepam—Anorexia—Chlorambucil—ovarian cancer	0.00454	0.0058	CcSEcCtD
Bromazepam—Malnutrition—Vinorelbine—ovarian cancer	0.00444	0.00568	CcSEcCtD
Bromazepam—Convulsion—Melphalan—ovarian cancer	0.0044	0.00563	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00439	0.00561	CcSEcCtD
Bromazepam—Muscular weakness—Paclitaxel—ovarian cancer	0.00438	0.00559	CcSEcCtD
Bromazepam—Cardiac failure—Docetaxel—ovarian cancer	0.00431	0.00551	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.0043	0.00549	CcSEcCtD
Bromazepam—Anaphylactic shock—Topotecan—ovarian cancer	0.00424	0.00542	CcSEcCtD
Bromazepam—Dyspepsia—Chlorambucil—ovarian cancer	0.00419	0.00536	CcSEcCtD
Bromazepam—Nervous system disorder—Topotecan—ovarian cancer	0.00416	0.00531	CcSEcCtD
Bromazepam—Anaphylactic shock—Melphalan—ovarian cancer	0.00415	0.0053	CcSEcCtD
Bromazepam—Decreased appetite—Chlorambucil—ovarian cancer	0.00414	0.00529	CcSEcCtD
Bromazepam—Skin disorder—Topotecan—ovarian cancer	0.00412	0.00526	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00411	0.00525	CcSEcCtD
Bromazepam—Fatigue—Chlorambucil—ovarian cancer	0.0041	0.00525	CcSEcCtD
Bromazepam—Tachycardia—Melphalan—ovarian cancer	0.00405	0.00518	CcSEcCtD
Bromazepam—Anorexia—Topotecan—ovarian cancer	0.00404	0.00516	CcSEcCtD
Bromazepam—Skin disorder—Melphalan—ovarian cancer	0.00403	0.00515	CcSEcCtD
Bromazepam—Anorexia—Melphalan—ovarian cancer	0.00395	0.00506	CcSEcCtD
Bromazepam—Ataxia—Docetaxel—ovarian cancer	0.00395	0.00505	CcSEcCtD
Bromazepam—Palpitations—Vinorelbine—ovarian cancer	0.00392	0.00502	CcSEcCtD
Bromazepam—Feeling abnormal—Chlorambucil—ovarian cancer	0.00392	0.00501	CcSEcCtD
Bromazepam—Hypotension—Melphalan—ovarian cancer	0.00388	0.00496	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00376	0.0048	CcSEcCtD
Bromazepam—Dyspepsia—Topotecan—ovarian cancer	0.00373	0.00477	CcSEcCtD
Bromazepam—Decreased appetite—Topotecan—ovarian cancer	0.00368	0.00471	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00366	0.00468	CcSEcCtD
Bromazepam—Fatigue—Topotecan—ovarian cancer	0.00365	0.00467	CcSEcCtD
Bromazepam—Dyspepsia—Melphalan—ovarian cancer	0.00365	0.00467	CcSEcCtD
Bromazepam—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00362	0.00463	CcSEcCtD
Bromazepam—Decreased appetite—Melphalan—ovarian cancer	0.00361	0.00461	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00358	0.00458	CcSEcCtD
Bromazepam—Fatigue—Melphalan—ovarian cancer	0.00358	0.00457	CcSEcCtD
Bromazepam—Nervous system disorder—Vinorelbine—ovarian cancer	0.00355	0.00454	CcSEcCtD
Bromazepam—Tachycardia—Vinorelbine—ovarian cancer	0.00354	0.00452	CcSEcCtD
Bromazepam—Skin disorder—Vinorelbine—ovarian cancer	0.00352	0.0045	CcSEcCtD
Bromazepam—Hypersensitivity—Chlorambucil—ovarian cancer	0.00351	0.00448	CcSEcCtD
Bromazepam—Feeling abnormal—Topotecan—ovarian cancer	0.00349	0.00446	CcSEcCtD
Bromazepam—Anorexia—Vinorelbine—ovarian cancer	0.00346	0.00442	CcSEcCtD
Bromazepam—Asthenia—Chlorambucil—ovarian cancer	0.00342	0.00437	CcSEcCtD
Bromazepam—Hypotension—Vinorelbine—ovarian cancer	0.00339	0.00433	CcSEcCtD
Bromazepam—Connective tissue disorder—Paclitaxel—ovarian cancer	0.00337	0.00431	CcSEcCtD
Bromazepam—Pruritus—Chlorambucil—ovarian cancer	0.00337	0.0043	CcSEcCtD
Bromazepam—Eye disorder—Paclitaxel—ovarian cancer	0.00321	0.0041	CcSEcCtD
Bromazepam—Cardiac disorder—Paclitaxel—ovarian cancer	0.00318	0.00407	CcSEcCtD
Bromazepam—Decreased appetite—Vinorelbine—ovarian cancer	0.00315	0.00403	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00313	0.004	CcSEcCtD
Bromazepam—Fatigue—Vinorelbine—ovarian cancer	0.00313	0.00399	CcSEcCtD
Bromazepam—Hypersensitivity—Topotecan—ovarian cancer	0.00312	0.00399	CcSEcCtD
Bromazepam—Hypersensitivity—Melphalan—ovarian cancer	0.00306	0.00391	CcSEcCtD
Bromazepam—GABRP—uterine cervix—ovarian cancer	0.00304	0.0506	CbGeAlD
Bromazepam—Asthenia—Topotecan—ovarian cancer	0.00304	0.00389	CcSEcCtD
Bromazepam—Vomiting—Chlorambucil—ovarian cancer	0.00303	0.00387	CcSEcCtD
Bromazepam—Mental disorder—Paclitaxel—ovarian cancer	0.00301	0.00384	CcSEcCtD
Bromazepam—Pruritus—Topotecan—ovarian cancer	0.003	0.00383	CcSEcCtD
Bromazepam—Malnutrition—Paclitaxel—ovarian cancer	0.00299	0.00382	CcSEcCtD
Bromazepam—Feeling abnormal—Vinorelbine—ovarian cancer	0.00299	0.00382	CcSEcCtD
Bromazepam—GABRE—myometrium—ovarian cancer	0.00298	0.0496	CbGeAlD
Bromazepam—Asthenia—Melphalan—ovarian cancer	0.00298	0.0038	CcSEcCtD
Bromazepam—Pruritus—Melphalan—ovarian cancer	0.00294	0.00375	CcSEcCtD
Bromazepam—Tension—Paclitaxel—ovarian cancer	0.00293	0.00375	CcSEcCtD
Bromazepam—Cardiac failure—Epirubicin—ovarian cancer	0.00291	0.00371	CcSEcCtD
Bromazepam—Nervousness—Paclitaxel—ovarian cancer	0.0029	0.00371	CcSEcCtD
Bromazepam—GABRP—decidua—ovarian cancer	0.0029	0.0482	CbGeAlD
Bromazepam—Muscle spasms—Paclitaxel—ovarian cancer	0.00287	0.00367	CcSEcCtD
Bromazepam—Connective tissue disorder—Docetaxel—ovarian cancer	0.00286	0.00365	CcSEcCtD
Bromazepam—Diplopia—Epirubicin—ovarian cancer	0.00284	0.00362	CcSEcCtD
Bromazepam—Nausea—Chlorambucil—ovarian cancer	0.00283	0.00361	CcSEcCtD
Bromazepam—Vision blurred—Paclitaxel—ovarian cancer	0.00282	0.0036	CcSEcCtD
Bromazepam—Dizziness—Topotecan—ovarian cancer	0.0028	0.00358	CcSEcCtD
Bromazepam—Tremor—Paclitaxel—ovarian cancer	0.0028	0.00358	CcSEcCtD
Bromazepam—GABRP—endometrium—ovarian cancer	0.00275	0.0458	CbGeAlD
Bromazepam—Agitation—Paclitaxel—ovarian cancer	0.00275	0.00351	CcSEcCtD
Bromazepam—Eye disorder—Docetaxel—ovarian cancer	0.00272	0.00347	CcSEcCtD
Bromazepam—Cardiac disorder—Docetaxel—ovarian cancer	0.0027	0.00345	CcSEcCtD
Bromazepam—Cardiac arrest—Epirubicin—ovarian cancer	0.0027	0.00345	CcSEcCtD
Bromazepam—Vomiting—Topotecan—ovarian cancer	0.00269	0.00344	CcSEcCtD
Bromazepam—Cardiac failure—Doxorubicin—ovarian cancer	0.00269	0.00344	CcSEcCtD
Bromazepam—Rash—Topotecan—ovarian cancer	0.00267	0.00341	CcSEcCtD
Bromazepam—Hypersensitivity—Vinorelbine—ovarian cancer	0.00267	0.00341	CcSEcCtD
Bromazepam—Dermatitis—Topotecan—ovarian cancer	0.00267	0.00341	CcSEcCtD
Bromazepam—Ataxia—Epirubicin—ovarian cancer	0.00267	0.00341	CcSEcCtD
Bromazepam—GABRG3—testis—ovarian cancer	0.00265	0.0442	CbGeAlD
Bromazepam—Headache—Topotecan—ovarian cancer	0.00265	0.00339	CcSEcCtD
Bromazepam—Palpitations—Paclitaxel—ovarian cancer	0.00264	0.00337	CcSEcCtD
Bromazepam—Vomiting—Melphalan—ovarian cancer	0.00264	0.00337	CcSEcCtD
Bromazepam—Diplopia—Doxorubicin—ovarian cancer	0.00262	0.00335	CcSEcCtD
Bromazepam—Rash—Melphalan—ovarian cancer	0.00262	0.00334	CcSEcCtD
Bromazepam—Dermatitis—Melphalan—ovarian cancer	0.00261	0.00334	CcSEcCtD
Bromazepam—Asthenia—Vinorelbine—ovarian cancer	0.0026	0.00332	CcSEcCtD
Bromazepam—Convulsion—Paclitaxel—ovarian cancer	0.00259	0.00331	CcSEcCtD
Bromazepam—Pruritus—Vinorelbine—ovarian cancer	0.00256	0.00328	CcSEcCtD
Bromazepam—Mental disorder—Docetaxel—ovarian cancer	0.00255	0.00326	CcSEcCtD
Bromazepam—GABRP—uterus—ovarian cancer	0.00253	0.0422	CbGeAlD
Bromazepam—Malnutrition—Docetaxel—ovarian cancer	0.00253	0.00324	CcSEcCtD
Bromazepam—GABRR1—testis—ovarian cancer	0.00253	0.0421	CbGeAlD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00253	0.00323	CcSEcCtD
Bromazepam—Nausea—Topotecan—ovarian cancer	0.00252	0.00322	CcSEcCtD
Bromazepam—Muscular weakness—Epirubicin—ovarian cancer	0.0025	0.0032	CcSEcCtD
Bromazepam—Cardiac arrest—Doxorubicin—ovarian cancer	0.0025	0.00319	CcSEcCtD
Bromazepam—Dry mouth—Paclitaxel—ovarian cancer	0.00249	0.00318	CcSEcCtD
Bromazepam—Ataxia—Doxorubicin—ovarian cancer	0.00247	0.00315	CcSEcCtD
Bromazepam—Nausea—Melphalan—ovarian cancer	0.00246	0.00315	CcSEcCtD
Bromazepam—Confusional state—Paclitaxel—ovarian cancer	0.00246	0.00314	CcSEcCtD
Bromazepam—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00244	0.00312	CcSEcCtD
Bromazepam—Muscle spasms—Docetaxel—ovarian cancer	0.00243	0.00311	CcSEcCtD
Bromazepam—Dizziness—Vinorelbine—ovarian cancer	0.0024	0.00306	CcSEcCtD
Bromazepam—Nervous system disorder—Paclitaxel—ovarian cancer	0.00239	0.00306	CcSEcCtD
Bromazepam—Tachycardia—Paclitaxel—ovarian cancer	0.00238	0.00304	CcSEcCtD
Bromazepam—Skin disorder—Paclitaxel—ovarian cancer	0.00237	0.00303	CcSEcCtD
Bromazepam—Anorexia—Paclitaxel—ovarian cancer	0.00232	0.00297	CcSEcCtD
Bromazepam—GABRE—uterine cervix—ovarian cancer	0.00232	0.0386	CbGeAlD
Bromazepam—Muscular weakness—Doxorubicin—ovarian cancer	0.00231	0.00296	CcSEcCtD
Bromazepam—Vomiting—Vinorelbine—ovarian cancer	0.0023	0.00295	CcSEcCtD
Bromazepam—GABRB1—vagina—ovarian cancer	0.0023	0.0383	CbGeAlD
Bromazepam—Rash—Vinorelbine—ovarian cancer	0.00229	0.00292	CcSEcCtD
Bromazepam—Dermatitis—Vinorelbine—ovarian cancer	0.00228	0.00292	CcSEcCtD
Bromazepam—Hypotension—Paclitaxel—ovarian cancer	0.00228	0.00291	CcSEcCtD
Bromazepam—GABRP—female reproductive system—ovarian cancer	0.00228	0.0379	CbGeAlD
Bromazepam—Headache—Vinorelbine—ovarian cancer	0.00227	0.0029	CcSEcCtD
Bromazepam—Palpitations—Docetaxel—ovarian cancer	0.00224	0.00286	CcSEcCtD
Bromazepam—GABRE—decidua—ovarian cancer	0.00221	0.0368	CbGeAlD
Bromazepam—GABRD—testis—ovarian cancer	0.0022	0.0366	CbGeAlD
Bromazepam—Convulsion—Docetaxel—ovarian cancer	0.00219	0.0028	CcSEcCtD
Bromazepam—Drowsiness—Epirubicin—ovarian cancer	0.00219	0.00279	CcSEcCtD
Bromazepam—Somnolence—Paclitaxel—ovarian cancer	0.00217	0.00277	CcSEcCtD
Bromazepam—Nausea—Vinorelbine—ovarian cancer	0.00215	0.00275	CcSEcCtD
Bromazepam—Dyspepsia—Paclitaxel—ovarian cancer	0.00215	0.00274	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00214	0.00274	CcSEcCtD
Bromazepam—Decreased appetite—Paclitaxel—ovarian cancer	0.00212	0.00271	CcSEcCtD
Bromazepam—Dry mouth—Docetaxel—ovarian cancer	0.00211	0.00269	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.0021	0.00269	CcSEcCtD
Bromazepam—Fatigue—Paclitaxel—ovarian cancer	0.0021	0.00269	CcSEcCtD
Bromazepam—GABRE—endometrium—ovarian cancer	0.0021	0.0349	CbGeAlD
Bromazepam—Confusional state—Docetaxel—ovarian cancer	0.00208	0.00266	CcSEcCtD
Bromazepam—Anaphylactic shock—Docetaxel—ovarian cancer	0.00207	0.00264	CcSEcCtD
Bromazepam—GABRP—vagina—ovarian cancer	0.00206	0.0343	CbGeAlD
Bromazepam—GABRA5—testis—ovarian cancer	0.00204	0.034	CbGeAlD
Bromazepam—Nervous system disorder—Docetaxel—ovarian cancer	0.00203	0.00259	CcSEcCtD
Bromazepam—Drowsiness—Doxorubicin—ovarian cancer	0.00202	0.00258	CcSEcCtD
Bromazepam—Tachycardia—Docetaxel—ovarian cancer	0.00202	0.00258	CcSEcCtD
Bromazepam—Feeling abnormal—Paclitaxel—ovarian cancer	0.00201	0.00257	CcSEcCtD
Bromazepam—Skin disorder—Docetaxel—ovarian cancer	0.00201	0.00257	CcSEcCtD
Bromazepam—Anorexia—Docetaxel—ovarian cancer	0.00197	0.00252	CcSEcCtD
Bromazepam—Hypotension—Docetaxel—ovarian cancer	0.00193	0.00247	CcSEcCtD
Bromazepam—Connective tissue disorder—Epirubicin—ovarian cancer	0.00193	0.00246	CcSEcCtD
Bromazepam—GABRR2—lymph node—ovarian cancer	0.00191	0.0317	CbGeAlD
Bromazepam—GABRA3—testis—ovarian cancer	0.0019	0.0316	CbGeAlD
Bromazepam—Somnolence—Docetaxel—ovarian cancer	0.00184	0.00235	CcSEcCtD
Bromazepam—Eye disorder—Epirubicin—ovarian cancer	0.00183	0.00234	CcSEcCtD
Bromazepam—Cardiac disorder—Epirubicin—ovarian cancer	0.00182	0.00233	CcSEcCtD
Bromazepam—Dyspepsia—Docetaxel—ovarian cancer	0.00182	0.00233	CcSEcCtD
Bromazepam—Decreased appetite—Docetaxel—ovarian cancer	0.0018	0.0023	CcSEcCtD
Bromazepam—Hypersensitivity—Paclitaxel—ovarian cancer	0.0018	0.0023	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00178	0.00228	CcSEcCtD
Bromazepam—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00178	0.00228	CcSEcCtD
Bromazepam—Fatigue—Docetaxel—ovarian cancer	0.00178	0.00228	CcSEcCtD
Bromazepam—Asthenia—Paclitaxel—ovarian cancer	0.00175	0.00224	CcSEcCtD
Bromazepam—GABRE—female reproductive system—ovarian cancer	0.00174	0.0289	CbGeAlD
Bromazepam—Pruritus—Paclitaxel—ovarian cancer	0.00172	0.0022	CcSEcCtD
Bromazepam—Mental disorder—Epirubicin—ovarian cancer	0.00172	0.0022	CcSEcCtD
Bromazepam—Malnutrition—Epirubicin—ovarian cancer	0.00171	0.00218	CcSEcCtD
Bromazepam—Feeling abnormal—Docetaxel—ovarian cancer	0.0017	0.00218	CcSEcCtD
Bromazepam—Eye disorder—Doxorubicin—ovarian cancer	0.0017	0.00217	CcSEcCtD
Bromazepam—Cardiac disorder—Doxorubicin—ovarian cancer	0.00168	0.00215	CcSEcCtD
Bromazepam—Tension—Epirubicin—ovarian cancer	0.00168	0.00214	CcSEcCtD
Bromazepam—Nervousness—Epirubicin—ovarian cancer	0.00166	0.00212	CcSEcCtD
Bromazepam—GABRB3—gonad—ovarian cancer	0.00165	0.0275	CbGeAlD
Bromazepam—Muscle spasms—Epirubicin—ovarian cancer	0.00164	0.0021	CcSEcCtD
Bromazepam—Dizziness—Paclitaxel—ovarian cancer	0.00161	0.00206	CcSEcCtD
Bromazepam—Vision blurred—Epirubicin—ovarian cancer	0.00161	0.00206	CcSEcCtD
Bromazepam—Mental disorder—Doxorubicin—ovarian cancer	0.00159	0.00203	CcSEcCtD
Bromazepam—GABRA2—vagina—ovarian cancer	0.00159	0.0264	CbGeAlD
Bromazepam—GABRE—female gonad—ovarian cancer	0.00158	0.0263	CbGeAlD
Bromazepam—Malnutrition—Doxorubicin—ovarian cancer	0.00158	0.00202	CcSEcCtD
Bromazepam—GABRE—vagina—ovarian cancer	0.00157	0.0262	CbGeAlD
Bromazepam—Agitation—Epirubicin—ovarian cancer	0.00157	0.00201	CcSEcCtD
Bromazepam—Tension—Doxorubicin—ovarian cancer	0.00155	0.00198	CcSEcCtD
Bromazepam—Vomiting—Paclitaxel—ovarian cancer	0.00155	0.00198	CcSEcCtD
Bromazepam—GABRB2—testis—ovarian cancer	0.00155	0.0258	CbGeAlD
Bromazepam—Rash—Paclitaxel—ovarian cancer	0.00154	0.00196	CcSEcCtD
Bromazepam—Dermatitis—Paclitaxel—ovarian cancer	0.00154	0.00196	CcSEcCtD
Bromazepam—Nervousness—Doxorubicin—ovarian cancer	0.00153	0.00196	CcSEcCtD
Bromazepam—Headache—Paclitaxel—ovarian cancer	0.00153	0.00195	CcSEcCtD
Bromazepam—Hypersensitivity—Docetaxel—ovarian cancer	0.00152	0.00195	CcSEcCtD
Bromazepam—Muscle spasms—Doxorubicin—ovarian cancer	0.00152	0.00194	CcSEcCtD
Bromazepam—Palpitations—Epirubicin—ovarian cancer	0.00151	0.00193	CcSEcCtD
Bromazepam—Vision blurred—Doxorubicin—ovarian cancer	0.00149	0.0019	CcSEcCtD
Bromazepam—Asthenia—Docetaxel—ovarian cancer	0.00148	0.0019	CcSEcCtD
Bromazepam—Convulsion—Epirubicin—ovarian cancer	0.00148	0.00189	CcSEcCtD
Bromazepam—GABRB3—female reproductive system—ovarian cancer	0.00147	0.0245	CbGeAlD
Bromazepam—Pruritus—Docetaxel—ovarian cancer	0.00146	0.00187	CcSEcCtD
Bromazepam—Agitation—Doxorubicin—ovarian cancer	0.00145	0.00186	CcSEcCtD
Bromazepam—Nausea—Paclitaxel—ovarian cancer	0.00145	0.00185	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00144	0.00185	CcSEcCtD
Bromazepam—Dry mouth—Epirubicin—ovarian cancer	0.00142	0.00182	CcSEcCtD
Bromazepam—Confusional state—Epirubicin—ovarian cancer	0.00141	0.0018	CcSEcCtD
Bromazepam—GABRE—testis—ovarian cancer	0.0014	0.0234	CbGeAlD
Bromazepam—Palpitations—Doxorubicin—ovarian cancer	0.0014	0.00178	CcSEcCtD
Bromazepam—Anaphylactic shock—Epirubicin—ovarian cancer	0.00139	0.00178	CcSEcCtD
Bromazepam—Convulsion—Doxorubicin—ovarian cancer	0.00137	0.00175	CcSEcCtD
Bromazepam—Nervous system disorder—Epirubicin—ovarian cancer	0.00137	0.00175	CcSEcCtD
Bromazepam—Dizziness—Docetaxel—ovarian cancer	0.00137	0.00175	CcSEcCtD
Bromazepam—Tachycardia—Epirubicin—ovarian cancer	0.00136	0.00174	CcSEcCtD
Bromazepam—Skin disorder—Epirubicin—ovarian cancer	0.00135	0.00173	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00134	0.00171	CcSEcCtD
Bromazepam—Anorexia—Epirubicin—ovarian cancer	0.00133	0.0017	CcSEcCtD
Bromazepam—Dry mouth—Doxorubicin—ovarian cancer	0.00132	0.00168	CcSEcCtD
Bromazepam—Vomiting—Docetaxel—ovarian cancer	0.00131	0.00168	CcSEcCtD
Bromazepam—Rash—Docetaxel—ovarian cancer	0.0013	0.00167	CcSEcCtD
Bromazepam—Hypotension—Epirubicin—ovarian cancer	0.0013	0.00166	CcSEcCtD
Bromazepam—Dermatitis—Docetaxel—ovarian cancer	0.0013	0.00166	CcSEcCtD
Bromazepam—Confusional state—Doxorubicin—ovarian cancer	0.0013	0.00166	CcSEcCtD
Bromazepam—Headache—Docetaxel—ovarian cancer	0.00129	0.00165	CcSEcCtD
Bromazepam—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00129	0.00165	CcSEcCtD
Bromazepam—Nervous system disorder—Doxorubicin—ovarian cancer	0.00126	0.00162	CcSEcCtD
Bromazepam—Tachycardia—Doxorubicin—ovarian cancer	0.00126	0.00161	CcSEcCtD
Bromazepam—Skin disorder—Doxorubicin—ovarian cancer	0.00125	0.0016	CcSEcCtD
Bromazepam—Somnolence—Epirubicin—ovarian cancer	0.00124	0.00158	CcSEcCtD
Bromazepam—Anorexia—Doxorubicin—ovarian cancer	0.00123	0.00157	CcSEcCtD
Bromazepam—Nausea—Docetaxel—ovarian cancer	0.00123	0.00157	CcSEcCtD
Bromazepam—Dyspepsia—Epirubicin—ovarian cancer	0.00123	0.00157	CcSEcCtD
Bromazepam—Decreased appetite—Epirubicin—ovarian cancer	0.00121	0.00155	CcSEcCtD
Bromazepam—Hypotension—Doxorubicin—ovarian cancer	0.00121	0.00154	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.0012	0.00154	CcSEcCtD
Bromazepam—Fatigue—Epirubicin—ovarian cancer	0.0012	0.00154	CcSEcCtD
Bromazepam—GABRB3—testis—ovarian cancer	0.00119	0.0198	CbGeAlD
Bromazepam—CYP2C19—vagina—ovarian cancer	0.00115	0.0192	CbGeAlD
Bromazepam—Feeling abnormal—Epirubicin—ovarian cancer	0.00115	0.00147	CcSEcCtD
Bromazepam—Somnolence—Doxorubicin—ovarian cancer	0.00115	0.00147	CcSEcCtD
Bromazepam—Dyspepsia—Doxorubicin—ovarian cancer	0.00114	0.00145	CcSEcCtD
Bromazepam—Decreased appetite—Doxorubicin—ovarian cancer	0.00112	0.00143	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00111	0.00142	CcSEcCtD
Bromazepam—Fatigue—Doxorubicin—ovarian cancer	0.00111	0.00142	CcSEcCtD
Bromazepam—Feeling abnormal—Doxorubicin—ovarian cancer	0.00106	0.00136	CcSEcCtD
Bromazepam—Hypersensitivity—Epirubicin—ovarian cancer	0.00103	0.00131	CcSEcCtD
Bromazepam—GABRA2—lymph node—ovarian cancer	0.00103	0.0171	CbGeAlD
Bromazepam—GABRE—lymph node—ovarian cancer	0.00102	0.0169	CbGeAlD
Bromazepam—Asthenia—Epirubicin—ovarian cancer	0.001	0.00128	CcSEcCtD
Bromazepam—Pruritus—Epirubicin—ovarian cancer	0.000986	0.00126	CcSEcCtD
Bromazepam—Hypersensitivity—Doxorubicin—ovarian cancer	0.00095	0.00121	CcSEcCtD
Bromazepam—CYP2E1—female reproductive system—ovarian cancer	0.000938	0.0156	CbGeAlD
Bromazepam—Asthenia—Doxorubicin—ovarian cancer	0.000925	0.00118	CcSEcCtD
Bromazepam—Dizziness—Epirubicin—ovarian cancer	0.000922	0.00118	CcSEcCtD
Bromazepam—Pruritus—Doxorubicin—ovarian cancer	0.000912	0.00117	CcSEcCtD
Bromazepam—Vomiting—Epirubicin—ovarian cancer	0.000886	0.00113	CcSEcCtD
Bromazepam—Rash—Epirubicin—ovarian cancer	0.000879	0.00112	CcSEcCtD
Bromazepam—Dermatitis—Epirubicin—ovarian cancer	0.000878	0.00112	CcSEcCtD
Bromazepam—Headache—Epirubicin—ovarian cancer	0.000873	0.00112	CcSEcCtD
Bromazepam—Dizziness—Doxorubicin—ovarian cancer	0.000853	0.00109	CcSEcCtD
Bromazepam—Nausea—Epirubicin—ovarian cancer	0.000828	0.00106	CcSEcCtD
Bromazepam—Vomiting—Doxorubicin—ovarian cancer	0.00082	0.00105	CcSEcCtD
Bromazepam—Rash—Doxorubicin—ovarian cancer	0.000813	0.00104	CcSEcCtD
Bromazepam—Dermatitis—Doxorubicin—ovarian cancer	0.000812	0.00104	CcSEcCtD
Bromazepam—Headache—Doxorubicin—ovarian cancer	0.000808	0.00103	CcSEcCtD
Bromazepam—Nausea—Doxorubicin—ovarian cancer	0.000766	0.000979	CcSEcCtD
Bromazepam—CYP2E1—testis—ovarian cancer	0.000757	0.0126	CbGeAlD
Bromazepam—CYP3A4—female reproductive system—ovarian cancer	0.000755	0.0126	CbGeAlD
Bromazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000255	0.00162	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000254	0.00161	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—CYP1B1—ovarian cancer	0.00025	0.00159	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000247	0.00156	CbGpPWpGaD
Bromazepam—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—ovarian cancer	0.000242	0.00154	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—MTOR—ovarian cancer	0.000229	0.00146	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000222	0.00141	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.00022	0.0014	CbGpPWpGaD
Bromazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000218	0.00139	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000217	0.00138	CbGpPWpGaD
Bromazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000215	0.00136	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000213	0.00135	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000212	0.00135	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—CASP3—ovarian cancer	0.000211	0.00134	CbGpPWpGaD
Bromazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.00021	0.00133	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000209	0.00133	CbGpPWpGaD
Bromazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000207	0.00131	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000205	0.0013	CbGpPWpGaD
Bromazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000205	0.0013	CbGpPWpGaD
Bromazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000205	0.0013	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000204	0.00129	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000204	0.00129	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—CTNNB1—ovarian cancer	0.000203	0.00129	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000202	0.00128	CbGpPWpGaD
Bromazepam—GABRR1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000201	0.00128	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000198	0.00126	CbGpPWpGaD
Bromazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000196	0.00124	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000195	0.00124	CbGpPWpGaD
Bromazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000193	0.00123	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	0.000193	0.00122	CbGpPWpGaD
Bromazepam—GABRR2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000192	0.00122	CbGpPWpGaD
Bromazepam—GABRQ—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000192	0.00122	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00019	0.00121	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000185	0.00118	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.000184	0.00117	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.000184	0.00117	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.00018	0.00114	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.00018	0.00114	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000179	0.00113	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000177	0.00113	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—STAT3—ovarian cancer	0.000177	0.00112	CbGpPWpGaD
Bromazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000177	0.00112	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000177	0.00112	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000174	0.0011	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000174	0.0011	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000172	0.00109	CbGpPWpGaD
Bromazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000172	0.00109	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000171	0.00108	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.00017	0.00108	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000169	0.00107	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—MAPK3—ovarian cancer	0.000169	0.00107	CbGpPWpGaD
Bromazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000169	0.00107	CbGpPWpGaD
Bromazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000169	0.00107	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000168	0.00106	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000168	0.00106	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000167	0.00106	CbGpPWpGaD
Bromazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000166	0.00105	CbGpPWpGaD
Bromazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000166	0.00105	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000165	0.00105	CbGpPWpGaD
Bromazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000165	0.00105	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000164	0.00104	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000164	0.00104	CbGpPWpGaD
Bromazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000162	0.00103	CbGpPWpGaD
Bromazepam—GABRR1—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000161	0.00102	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—MAPK1—ovarian cancer	0.000161	0.00102	CbGpPWpGaD
Bromazepam—GABRG3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000158	0.001	CbGpPWpGaD
Bromazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000157	0.000998	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000156	0.000992	CbGpPWpGaD
Bromazepam—GABRB1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000156	0.000988	CbGpPWpGaD
Bromazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000155	0.000985	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000154	0.00098	CbGpPWpGaD
Bromazepam—GABRR1—Neuronal System—MAPK1—ovarian cancer	0.000154	0.000978	CbGpPWpGaD
Bromazepam—GABRR2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000154	0.000977	CbGpPWpGaD
Bromazepam—GABRQ—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000154	0.000977	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000153	0.000973	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—NME2—ovarian cancer	0.000152	0.000967	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.000151	0.000961	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	0.00015	0.000954	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000149	0.000944	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000148	0.000941	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000148	0.000939	CbGpPWpGaD
Bromazepam—GABRA6—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000147	0.000935	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—MAPK1—ovarian cancer	0.000147	0.000933	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—MAPK1—ovarian cancer	0.000147	0.000933	CbGpPWpGaD
Bromazepam—GABRA4—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000145	0.000923	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000144	0.000914	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000143	0.000907	CbGpPWpGaD
Bromazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000142	0.000901	CbGpPWpGaD
Bromazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000141	0.000897	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000141	0.000896	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000141	0.000895	CbGpPWpGaD
Bromazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000138	0.000876	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000138	0.000875	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000138	0.000875	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000138	0.000875	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000137	0.00087	CbGpPWpGaD
Bromazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000135	0.00086	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000135	0.000855	CbGpPWpGaD
Bromazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000133	0.000845	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000133	0.000844	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000132	0.00084	CbGpPWpGaD
Bromazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000132	0.000839	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000131	0.000834	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.00013	0.000827	CbGpPWpGaD
Bromazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.00013	0.000824	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—HRAS—ovarian cancer	0.000129	0.000821	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000129	0.00082	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000129	0.000819	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000127	0.000805	CbGpPWpGaD
Bromazepam—GABRG3—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000127	0.000805	CbGpPWpGaD
Bromazepam—GABRB1—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000125	0.000793	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000125	0.000791	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000124	0.000786	CbGpPWpGaD
Bromazepam—GABRR1—Neuronal System—HRAS—ovarian cancer	0.000124	0.000785	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000122	0.000772	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—MAPK1—ovarian cancer	0.000121	0.000768	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—MAPK1—ovarian cancer	0.000119	0.000757	CbGpPWpGaD
Bromazepam—GABRA6—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000118	0.00075	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—HRAS—ovarian cancer	0.000118	0.000749	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—HRAS—ovarian cancer	0.000118	0.000749	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—NME2—ovarian cancer	0.000118	0.000746	CbGpPWpGaD
Bromazepam—GABRA4—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000117	0.000741	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000116	0.000736	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000116	0.000736	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000114	0.000726	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—AKT1—ovarian cancer	0.000114	0.000725	CbGpPWpGaD
Bromazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000114	0.000721	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000113	0.000716	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—MAPK1—ovarian cancer	0.000113	0.000716	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—MAPK1—ovarian cancer	0.000111	0.000707	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.000111	0.000703	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000107	0.000678	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000106	0.000675	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000104	0.000658	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—MAPK1—ovarian cancer	0.000102	0.000647	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000102	0.000646	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.0001	0.000635	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	9.97e-05	0.000633	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL6—ovarian cancer	9.96e-05	0.000632	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—HRAS—ovarian cancer	9.94e-05	0.000631	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—MAPK1—ovarian cancer	9.9e-05	0.000628	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYTB—ovarian cancer	9.82e-05	0.000623	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—HRAS—ovarian cancer	9.76e-05	0.00062	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—MAPK1—ovarian cancer	9.72e-05	0.000617	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—HRAS—ovarian cancer	9.72e-05	0.000617	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—HRAS—ovarian cancer	9.57e-05	0.000608	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—MAPK1—ovarian cancer	9.55e-05	0.000606	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—MAPK1—ovarian cancer	9.49e-05	0.000602	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—MAPK1—ovarian cancer	9.32e-05	0.000591	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—NME2—ovarian cancer	9.16e-05	0.000582	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—HRAS—ovarian cancer	9.06e-05	0.000575	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—HRAS—ovarian cancer	8.94e-05	0.000568	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PPP1CC—ovarian cancer	8.58e-05	0.000545	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—BRIP1—ovarian cancer	8.58e-05	0.000545	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	8.53e-05	0.000542	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—HRAS—ovarian cancer	8.18e-05	0.000519	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—MAPK1—ovarian cancer	8.14e-05	0.000517	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	8.13e-05	0.000516	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—HRAS—ovarian cancer	7.94e-05	0.000504	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—HRAS—ovarian cancer	7.8e-05	0.000495	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	7.77e-05	0.000493	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—HRAS—ovarian cancer	7.67e-05	0.000487	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—HRAS—ovarian cancer	7.62e-05	0.000484	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYTB—ovarian cancer	7.58e-05	0.000481	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—HRAS—ovarian cancer	7.48e-05	0.000475	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	7.41e-05	0.00047	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—NME2—ovarian cancer	7.07e-05	0.000449	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—BRIP1—ovarian cancer	6.62e-05	0.00042	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PPP1CC—ovarian cancer	6.62e-05	0.00042	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—HRAS—ovarian cancer	6.54e-05	0.000415	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	6.34e-05	0.000402	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYTB—ovarian cancer	5.9e-05	0.000375	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.77e-05	0.000366	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—YAP1—ovarian cancer	5.76e-05	0.000365	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—BRIP1—ovarian cancer	5.16e-05	0.000328	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PPP1CC—ovarian cancer	5.16e-05	0.000328	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.83e-05	0.000306	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—FASN—ovarian cancer	4.69e-05	0.000298	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SLC5A5—ovarian cancer	4.62e-05	0.000293	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYTB—ovarian cancer	4.56e-05	0.000289	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SLC2A1—ovarian cancer	4.46e-05	0.000283	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—YAP1—ovarian cancer	4.44e-05	0.000282	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.4e-05	0.000279	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYP1B1—ovarian cancer	4.27e-05	0.000271	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—BRIP1—ovarian cancer	3.98e-05	0.000253	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PPP1CC—ovarian cancer	3.98e-05	0.000253	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.86e-05	0.000245	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	3.79e-05	0.000241	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.76e-05	0.000239	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—FASN—ovarian cancer	3.62e-05	0.00023	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SLC5A5—ovarian cancer	3.56e-05	0.000226	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ABCB1—ovarian cancer	3.52e-05	0.000223	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—YAP1—ovarian cancer	3.46e-05	0.00022	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—TYMS—ovarian cancer	3.46e-05	0.000219	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SLC2A1—ovarian cancer	3.44e-05	0.000218	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.43e-05	0.000217	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.37e-05	0.000214	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP1B1—ovarian cancer	3.3e-05	0.000209	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.01e-05	0.000191	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	2.92e-05	0.000186	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.91e-05	0.000185	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—FASN—ovarian cancer	2.82e-05	0.000179	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CAV1—ovarian cancer	2.79e-05	0.000177	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SLC5A5—ovarian cancer	2.78e-05	0.000176	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ABCB1—ovarian cancer	2.72e-05	0.000172	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SLC2A1—ovarian cancer	2.68e-05	0.00017	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—YAP1—ovarian cancer	2.67e-05	0.00017	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—TYMS—ovarian cancer	2.67e-05	0.000169	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.62e-05	0.000167	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP1B1—ovarian cancer	2.57e-05	0.000163	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PIK3CG—ovarian cancer	2.54e-05	0.000161	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	2.28e-05	0.000145	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.27e-05	0.000144	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PIK3CD—ovarian cancer	2.23e-05	0.000142	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—FASN—ovarian cancer	2.18e-05	0.000138	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CAV1—ovarian cancer	2.15e-05	0.000136	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.14e-05	0.000136	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ABCB1—ovarian cancer	2.12e-05	0.000134	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—TYMS—ovarian cancer	2.08e-05	0.000132	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.07e-05	0.000131	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.05e-05	0.00013	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.98e-05	0.000126	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PIK3CG—ovarian cancer	1.96e-05	0.000124	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PIK3CB—ovarian cancer	1.94e-05	0.000123	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.76e-05	0.000112	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PIK3CD—ovarian cancer	1.72e-05	0.000109	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PTEN—ovarian cancer	1.68e-05	0.000107	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CAV1—ovarian cancer	1.67e-05	0.000106	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.63e-05	0.000104	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—TYMS—ovarian cancer	1.6e-05	0.000102	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.6e-05	0.000102	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PIK3CG—ovarian cancer	1.53e-05	9.68e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.5e-05	9.52e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.34e-05	8.51e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PTEN—ovarian cancer	1.3e-05	8.23e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CAV1—ovarian cancer	1.29e-05	8.2e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PIK3CA—ovarian cancer	1.19e-05	7.52e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.18e-05	7.47e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.17e-05	7.42e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.03e-05	6.57e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PTEN—ovarian cancer	1.01e-05	6.41e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—AKT1—ovarian cancer	9.68e-06	6.15e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PIK3CA—ovarian cancer	9.14e-06	5.8e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PIK3CB—ovarian cancer	9.02e-06	5.73e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PTEN—ovarian cancer	7.79e-06	4.95e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—AKT1—ovarian cancer	7.47e-06	4.74e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PIK3CA—ovarian cancer	7.13e-06	4.52e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—AKT1—ovarian cancer	5.82e-06	3.69e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PIK3CA—ovarian cancer	5.5e-06	3.49e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—AKT1—ovarian cancer	4.49e-06	2.85e-05	CbGpPWpGaD
